Rice Hall James & Associates LLC Sells 8,740 Shares of U.S. Physical Therapy, Inc. (USPH)

Rice Hall James & Associates LLC lessened its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 42.2% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 11,993 shares of the company’s stock after selling 8,740 shares during the quarter. Rice Hall James & Associates LLC’s holdings in U.S. Physical Therapy were worth $1,422,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in USPH. California Public Employees Retirement System raised its holdings in U.S. Physical Therapy by 9.7% during the 1st quarter. California Public Employees Retirement System now owns 41,165 shares of the company’s stock valued at $3,347,000 after buying an additional 3,640 shares during the period. Principal Financial Group Inc. raised its holdings in U.S. Physical Therapy by 2.5% during the 1st quarter. Principal Financial Group Inc. now owns 99,799 shares of the company’s stock valued at $8,114,000 after buying an additional 2,435 shares during the period. Allianz Asset Management GmbH purchased a new stake in U.S. Physical Therapy during the 1st quarter valued at $384,000. WINTON GROUP Ltd bought a new position in U.S. Physical Therapy in the 1st quarter valued at $679,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in U.S. Physical Therapy in the 1st quarter valued at $268,000. Institutional investors own 97.98% of the company’s stock.

In other news, CEO Christopher J. Reading sold 1,232 shares of the stock in a transaction on Tuesday, August 7th. The stock was sold at an average price of $116.29, for a total transaction of $143,269.28. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Glenn Mcdowell sold 6,204 shares of the stock in a transaction on Friday, August 3rd. The stock was sold at an average price of $114.81, for a total value of $712,281.24. The disclosure for this sale can be found here. Insiders sold a total of 32,054 shares of company stock worth $3,713,012 in the last ninety days. 2.50% of the stock is currently owned by corporate insiders.



Shares of U.S. Physical Therapy stock opened at $106.00 on Monday. The firm has a market capitalization of $1.34 billion, a price-to-earnings ratio of 46.90, a price-to-earnings-growth ratio of 3.76 and a beta of 1.12. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.06 and a current ratio of 2.06. U.S. Physical Therapy, Inc. has a 52 week low of $64.45 and a 52 week high of $129.65.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, August 2nd. The company reported $0.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.05. The company had revenue of $115.10 million for the quarter, compared to the consensus estimate of $111.77 million. U.S. Physical Therapy had a return on equity of 13.81% and a net margin of 5.03%. U.S. Physical Therapy’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.59 EPS. On average, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current fiscal year.

Several equities analysts have commented on the company. Barrington Research reaffirmed a “hold” rating on shares of U.S. Physical Therapy in a research report on Friday, August 3rd. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $129.00 price objective on the stock in a research report on Tuesday, August 7th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a $105.00 price objective on shares of U.S. Physical Therapy in a research report on Friday, August 3rd. Four investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $108.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Further Reading: Hedge Funds

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply